Johnson & Johnson Shares Rise on Reported Apollo Talks for Orthopedics Unit

Johnson & Johnson Shares Rise on Reported Apollo Talks for Orthopedics Unit

Mon, September 14, 2026 at 4:31 PM GMT+3 1 min read

• JNJ +0.33%
• APO -1.02%

Johnson & Johnson (NYSE:JNJ) shares rose 1.3% to $268.96 in pre-market trading on Monday following a report that Apollo Global Management (NYSE:APO) is in discussions to acquire the healthcare group's orthopedics business.

Bloomberg News reported on Friday that a potential transaction could value the division at close to $20 billion, citing people familiar with the matter.

According to the report, an agreement could be reached within several weeks. No transaction was confirmed in the supplied information.

Orthopedics Unit Generated $9.3 Billion in 2025

Johnson & Johnson's orthopedics division generated $9.3 billion in revenue in 2025.

The business has also faced thousands of lawsuits relating to its hip replacement devices.

Johnson & Johnson shares moved higher in pre-market trading as investors assessed the reported discussions and the potential value of a transaction involving the orthopedics unit.

Johnson & Johnson stock price

Apollo Global Management stock price